Purav Patel's Insider Trades & SAST Disclosures
Purav Patel's most recent trade in Reviva Pharmaceuticals Holdings Inc. was a trade of 8,200 Stock Option (right to buy) done . Disclosure was reported to the exchange on Dec. 10, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Purav Patel.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Reviva Pharmaceuticals Hol... | Purav Patel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2024 | 8,200 | 8,200 | - | - | Stock Option (right to buy) | |
| Reviva Pharmaceuticals Hol... | Purav Patel | Director | Purchase of securities on an exchange or from another person at price $ 4.69 per share. | 18 Nov 2022 | 3,000 | 43,547 | - | 4.7 | 14,070 | Common Stock, par value $0.0001 per share |
| Reviva Pharmaceuticals Hol... | Purav Patel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Nov 2022 | 3,900 | 3,900 | - | - | Stock Option (right to buy) | |
| Reviva Pharmaceuticals Hol... | Purav Patel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2021 | 5,300 | 5,300 | - | - | Stock Option (right to buy) | |
| Reviva Pharmaceuticals Hol... | Purav Patel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2021 | 15,227 | 15,227 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges